Tuesday, 16 Jul 2019

You are here

Potential Reasons Why Osteoarthritis Preferentially Affects Women

Researchers from Augusta University have examined exosomes from patients with knee osteoarthritis (OA) to enhance our molecular understanding of the pathogenesis of OA. (Citation source http://buff.ly/2tuDZ3v)

Exosomes play a vital role in cell-to-cell communication. By obtaining samples from OA patient synovial fluid, researchers analyzed the exosomes that carry microRNAs (miRNAs) that regulate gene expression. Their supposition was that molecular profiling of synovial fluid derived exosomal miRNAs may increase the understanding of OA progression.

They found distinct differences in miRNA activity between men and women with OA.  Interesting, in light of the fact that OA is more common in women than men; the reasons for which are unknown.

The synovial fluid of men showed 69 downregulated and 45 upregulated miRNAs, while in women there were 91 downregulated and 53 upregulated miRNAs.

Women were more likely than men to show a deactivation or alteration of miRNAs that are important for estrogen signaling and collagen production.

Thus the loss of estrogen levels during menopausal years may be associated with an increased risk of OA. It has been previously noted that women on hormone replacement therapy have a lower risk of OA.

One potential use of this stems from their efforts showing that blocking estrogen availability in exosomes using aromatase inhibitors may lead to a reduction in miRNAs.

The study also disclosed that one particular miRNA, called MiR-504-3p, was upregulated in both men and women with OA. The significance of this is unknown but may related to cartilage degeneration. 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Safety Concerns Offset the Modest Improvements of Tanezumab in Osteoarthritis

JAMA reports that although tanezumab is modestly effective in moderate to severe osteoarthritis (knee or hip), with statistically significant improvements in pain and physical function, the tanezumab (TNZ) treated patients had more joint safety events and total joint replacements than patients treated with placebo.

Benefits vs Harms for Osteoporosis Drug Continuation or Discontinuation

While it is clear that long-term bisphosphonate therapies reduce fracture risk in women with osteoporosis, it is unclear how to counter-balance these benefits against rare serious harms and how to optimize therapeutic benefits with appropriate drug holidays. A systematic analysis of 48 studies compared long-term osteoporosis drug treatment (ODT) (>3 years) versus control versus ODT continuation versus durg discontinuation, to examine incident fractures or harms.

Mortality from Falls in the Elderly

JAMA reports that there is a trend of increasing mortality from falls in older US adults between 2000 to 2016 and that mortality rates are increased with increasing age. 

Knee Injuries Increases Osteoarthritis Risk

A systematic review of the medical literature shows anterior cruciate ligament (ACL), meniscus or combined ACL and meniscus injury significantly increases the risk of future knee osteoarthritis (OA).

The metanalysis comprised 53 studies and nearly 1 million participants, including 185,219 with ACL injury (mean age 28 years), 83,267 with meniscal injury (mean 38 years) and 725,362 with combined injury (mean 31 years).

Additive Effects of Insomnia and Depression on Osteoarthritis

A study of osteoarthritis patients, finds that pain is the primary driver for health care utilization, and that the presence of insomnia or depression augments health care use.

 A total of 2976 OA patients were followed for 3 years and assessed for pain (Graded Chronic Pain Scale), insomnia (Insomnia Severity Index), and depression (Patient Health Questionnaire‐8), and health care use (from electronic health records).